Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone and D-Cycloserine for Fear Extinction in PTSD
NCT00674570Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2009
- Primary completion
- Jun 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone, d-cycloserine in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Jan 2009; status: completed.
02
Drugs
hydrocortisoned-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00674570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674570.